Randomized, Crossover, Pharmacodynamic Study Comparing the Effects of Two Proton Pump Inhibitors.

Trial Profile

Randomized, Crossover, Pharmacodynamic Study Comparing the Effects of Two Proton Pump Inhibitors.

Completed
Phase of Trial: Phase III

Latest Information Update: 19 Mar 2015

At a glance

  • Drugs Omeprazole/sodium bicarbonate (Primary) ; Lansoprazole
  • Indications Erosive oesophagitis; Gastro-oesophageal reflux; Heartburn; Peptic ulcer
  • Focus Pharmacodynamics
  • Sponsors Bayer; Merck Sharp & Dohme; Schering-Plough
  • Most Recent Events

    • 03 Feb 2010 Planned end date changed from 1 Dec 2009 to 1 Jan 2010 as reported by ClinicalTrials.gov.
    • 03 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Nov 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top